Weighing the Risks of Perimyocarditis With the Benefits of SARS-CoV-2 mRNA Vaccination in Adolescents.
Jhaveri R, Adler-Shohet FC, Blyth CC, Chiotos K, Gerber JS, Green M, Kociolek L, Martin-Blais R, Palazzi D, Shane AL, Schuster JE, Shulman ST, Storch GA, Weinberg GA, Zaoutis T. Weighing the Risks of Perimyocarditis With the Benefits of SARS-CoV-2 mRNA Vaccination in Adolescents. J Pediatric Infect Dis Soc. 2021 Nov 11; 10(10):937-939.